Clinical Trial

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated November 5, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This research is studying a device already approved by the Food and Drug Administration (FDA) to treat wound closures. Researchers are studying a large group of people to continue to learn information about the safety of the STRATAFIX suture and how people's bodies react to using it over a long period of time. This research will provide additional information about using STRATAFIX sutures to close surgical wounds.
Trial Details
NCT Number NCT07225101
Lead Sponsor University of Michigan
Collaborators: Johnson & Johnson
Conditions Wound Closure, Brain Tumor Adult, Spine, Neurovascular, Hemorrhagic Stroke, Intracerebral, Traumatic Brain Injury
Enrollment 160 participants
Start Date 2025-11-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-05